<SEC-DOCUMENT>0001144204-18-051008.txt : 20180927
<SEC-HEADER>0001144204-18-051008.hdr.sgml : 20180927
<ACCEPTANCE-DATETIME>20180927084625
ACCESSION NUMBER:		0001144204-18-051008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180926
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180927
DATE AS OF CHANGE:		20180927

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		181089549

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		203 787 7888

	MAIL ADDRESS:	
		STREET 1:		4 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv503567_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D. C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B><BR>
<B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B><BR>
<B>SECURITIES EXCHANGE ACT OF 1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
September 26, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>PRECIPIO,
INC.</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(Exact Name of Registrant as Specified in Its Charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(State of Incorporation)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>001-36439</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(Commission File Number)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1789357</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(I.R.S. Employer Identification No.)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4 Science Park, New Haven, CT 06511</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Address of principal executive offices)
(Zip Code)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(203) 787-7888</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Registrant's telephone number, including
area code)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B><BR>
<I>(Former name, former address and former fiscal year, if changed since last report date)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Emerging growth company </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Item&nbsp;3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As previously reported, on March 26, 2018, Precipio, Inc. (the
 &ldquo;Company&rdquo;) received a letter from The Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;) that the closing bid price for our
common stock had been below $1.00 for the previous 30 consecutive business days, and that we were therefore not in compliance with
the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The
notice indicated that we would have 180 calendar days, or until September 24, 2018, to regain compliance with this requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 25, 2018, Nasdaq notified us that we are eligible
for an extension to comply with the minimum $1.00 bid price requirement through March 25, 2019, by which date we must evidence
compliance for at least ten consecutive business days. If compliance cannot be demonstrated by March 25, 2019 Nasdaq will provide
written notification that our common stock will be delisted. In the event of such a notification, we may appeal Nasdaq&rsquo;s
determination, but there can be no assurance Nasdaq would grant any such request for continued listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is presently evaluating various courses of action
to regain compliance with the Bid Price Rule. However, there can be no assurance that the Company will be able to regain compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company issued a press release on September 26, 2018 stating
that it had received the letter from Nasdaq. A copy of the please release is filed as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statement in this report that are not strictly historical in
nature constitute &ldquo;forward-looking statements.&rdquo; Such statements include, but are not limited to, the Company&rsquo;s
ability to regain compliance with Nasdaq&rsquo;s continued listing standards. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors, which may cause actual results to be materially different from any results expressed
or implied by such forward-looking statements. Risk factors that may cause actual results to differ are discussed in the Company&rsquo;s
SEC filings. All forward-looking statements are qualified in their entirety by this cautionary statement. The Company is providing
this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this
report as a result of new information, future events or otherwise.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><B>Item
9.01</B>&nbsp;<B>Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 8%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>No.</B></P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 90%"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><A HREF="tv503567_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><A HREF="tv503567_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press Release of Precipio, Inc. issued September 26, 2018</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><B>PRECIPIO, INC.</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 46%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ilan Danieli</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Ilan Danieli</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#9;September 27, 2018&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv503567_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Precipio Granted 180 Day NASDAQ Extension
to Regain Compliance </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Enables Company to execute on strategic
and commercial initiatives with the goal of meeting the minimum $1.00 price target </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEW HAVEN, CT, (September 26<SUP>th</SUP>, 2018) &ndash;
</B>Specialty cancer diagnostics company <FONT STYLE="color: #1155CC"><U>Precipio, Inc.</U></FONT> (<FONT STYLE="color: #1155CC"><U>NASDAQ:
PRPO</U></FONT>), today announced notification by the NASDAQ Stock Market that the Company has been granted a 180-day extension
to allow the Company to meet the required minimum $1.00 per share closing bid price of its common stock for 10 consecutive business
days for continued inclusion on the Nasdaq Capital Market Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;These additional six months provide more time for our
operational, commercial and strategic initiatives to materialize, and for management to build the value of the company,&rdquo;
commented Ilan Danieli, Precipio&rsquo;s CEO. &ldquo;We expect this to begin relieving the uncertainty we&rsquo;ve observed from
our numerous shareholder inquiries on the topic.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following its review process, Nasdaq determined Precipio is
eligible for an extension of an additional 180 calendar days to allow it to regain compliance with the minimum share price requirement.
Assuming that during this extension period, the closing bid price of the Company&rsquo;s common stock meets the requirements of
above $1.00 for the required minimum 10 consecutive business days, and provided that the Company meets all the other listing requirements,
Nasdaq will provide the Company with written confirmation that it is compliant with its listing requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Precipio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precipio has built a platform designed to eradicate the problem
of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality
diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions
specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard&rsquo;s Dana-Farber
Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information,
please visit <FONT STYLE="color: blue"><U>www.precipiodx.com</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements in this press release constitute &ldquo;forward-looking
statements,&rdquo; within the meaning of federal securities laws, including statements related to ICP technology, including financial
projections related thereto and potential market opportunity, plans and prospects and other statements containing the words &ldquo;anticipate,&rdquo;
 &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo;
 &ldquo;should,&rdquo; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. The Company's actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results
or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company&rsquo;s
definitive proxy statement filed on May 29, 2018, the Company&rsquo;s Quarterly Report on Form 10-Q for the quarter ended June
30, 2018 and on the Annual Report on Form 10-K for the year ended December 31, 2017 as well as the Company&rsquo;s prior filings
and from time to time in the Company&rsquo;s subsequent filings with the Securities and Exchange Commission. Any change in such
factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred
to in such statements. All information in this press release is as of the date of the release and the Company does not undertake
any duty to update this information, including any forward-looking statements, unless required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inquiries:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC"><B><U>investors@precipiodx.com</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>+1-203-787-7888</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"></P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! 4T# 2(  A$! Q$!_\0
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M,N(]Z[>XQZUR_P#97Q+_ .ABT?\ \!3_ /$UWM%4I6%8X+^ROB7_ -#%H_\
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M\GBKQ-Y:7YC\JULXSE;9#U_'_$_A'\6_^1-B_P"OZ#_T*N[Q7"?%O_D38O\
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MJ'W((%9FE"XN+:!X=4!CC 5X?LZJ4QU0^A'2FEU TXKQ9;DV[(T<PB64JV.
M21C(ZX(_E3KJZ2TB5Y,D,ZH O4EB /YUEZK%+=ZA!;V3^1>1IYAN>OE(3C&W
MHVXCH>.,^E1O;W5IJ5M<ZA<_;;?>$C^0)Y#MP&VCALYQD],_6BPC0DOKI)&5
M=+N74' 97CPWN,M47]M(X@%O:SS22[QY8VJR%" P;)'.2*AM%U*^@:8:@L0,
MLBA!;J<!7*CDGVJ.2Q-KJ%E!#<LLKQSNT[@,68E"21TIV0&C#>W$DJH^FW$2
MGJ[.A _)B:8^J@S216MI/=-&=LC1[0JMZ;F(!/TSBIK2.:)6$]Y]H)/RG8JX
M_*JF@RQKIZV9(6YMR4FC)^8-DY;Z'KGOFD!8-[<B!9/[-N"Y)!CWID#U^]C]
M:KQ:O/,\JII5T3$^Q_GCX. ?[WH16K6?IO\ Q\ZG_P!??_M-*- +X.5R1CVK
M*FUZ"!7E>WN3:HYC-PJ97=G&  <GGC.,9K6K M[>2Z\,"&$ N9B0"<<"8D_H
M*%;J#-&VU)9YFAEMYK:4)Y@6;'S+Z@@D<=QVS40UGS4\V"PO)[?M,BC##U4$
M@D?0?3-5=;AEN+DPP@F1["<*H_B^:/C\>GXUI6U_:3V0N8IHU@"\DD+LQV/H
M1Z4-=0&MJ&^"*>SMY+N.09#1,HQ]=Q'^14+:PL0E%S:7%NZ1-,%?:=ZKUVD$
MC(XX]ZSK-[J>\*6EQ]FM[EYKE"8@Q904 .#T!)9OQIMW&^S5%O;AYKB"T?R<
MJJJ8V7E@!WR,'TQ[T[+8+FJ-1NV4,-(NL$9_UD?_ ,55^-B\:LR%&(R5.,CV
MXJA#!="5)&U'=%U\KREZ>F>M7RZ#JRCZFDQCJ***0!1110 AZ&EHHH .U%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !Z5Y5X^_Y&)_^N:_
MRHHK6C\1,MCM/#7^J@_[!UM_[/6CK'_(/_[;0_\ HQ:**A_$/H+I'_'@?^N\
MW_HQJYCXA_ZK3O\ ?D_D***</C$]CGO"G_(SV/\ O-_Z":U/B-_Q\6G^Y_6B
MBM?^7B)^R;7@#_D64_Z[2?SK;T[_ (^-1_Z^O_9$HHK&7Q,M;%ZL[1/^05'_
M -=)/_0VHHI=!BR_\AZV_P"O:7_T*.O/_$?_ "/2?[Z445</T)9Z&_\ R&8/
M^N#_ /H2U2UG[\__ %X7'_LM%%2MQO8\H'W!]*[Z[_Y!.D?]>J_R%%%;3W1,
#3__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
